These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 13311262)

  • 1. [Effect of lipocaic on cholesterine level and chylomicron content in blood].
    MIANO G; CASSANO A; SOLINAS L
    Riforma Med; 1956 Feb; 70(7):173-9. PubMed ID: 13311262
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of lipocaine on the level of cholesterol in the blood].
    ZHUKOV NA
    Probl Endokrinol Gormonoter; 1960; 6():91-3. PubMed ID: 13847390
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of lipocaic on the development of experimental atherosclerosis].
    VOSKRESENSKII ON
    Probl Endokrinol Gormonoter; 1962; 8():46-51. PubMed ID: 14040111
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of lipocaine on nutritional hypercholesterinemia and experimental atherosclerosis in rabbits].
    GOL'BER LM; GOLUBEVA OG
    Probl Endokrinol Gormonoter; 1961; 7():7-14. PubMed ID: 13899601
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparison of erythrocyte and chylomicron electrophoretic migration times and serum cholesterol levels in atheroma.
    DAVIES DF
    Clin Sci; 1959 May; 18():263-8. PubMed ID: 13814380
    [No Abstract]   [Full Text] [Related]  

  • 6. Chylomicron metabolism: alterations of absorbed labeled lipid.
    BURR WW; McPHERSON JC; TIDWELL HC
    Am J Physiol; 1958 Dec; 195(3):769-72. PubMed ID: 13606256
    [No Abstract]   [Full Text] [Related]  

  • 7. Exchange of iodine-131-labeled chylomicron protein in vitro.
    HOFMANN AF
    Am J Physiol; 1960 Sep; 199():433-6. PubMed ID: 13715094
    [No Abstract]   [Full Text] [Related]  

  • 8. The oxidation of 14C labelled chylomicron fat by the rat.
    MORRIS B
    Q J Exp Physiol Cogn Med Sci; 1958 Jan; 43(1):65-74. PubMed ID: 13494683
    [No Abstract]   [Full Text] [Related]  

  • 9. Micro methods for the determination of chylomicron counts, fatty esters, lipid phosphorus and cholesterol in blood serum.
    CLAYTON MM; ADAMS PA; MAHONEY GB; RANDALL SW; SCHWARTZ T
    Clin Chem; 1959 Oct; 5():426-44. PubMed ID: 13810587
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of unesterified fatty acid transport in chylomicron metabolism.
    FREDRICKSON DS; McCOLLESTER DL; ONO K
    J Clin Invest; 1958 Oct; 37(10):1333-41. PubMed ID: 13575533
    [No Abstract]   [Full Text] [Related]  

  • 11. Chylomicron and clearing reaction: effect of heat and of refrigeration.
    SWANK RL; ROTH ES
    Proc Soc Exp Biol Med; 1954 May; 86(1):74-7. PubMed ID: 13177593
    [No Abstract]   [Full Text] [Related]  

  • 12. Metabolism of chylomicron proteins in the dog.
    RODBELL M; FREDRICKSON DS; ONO K
    J Biol Chem; 1959 Mar; 234(3):567-71. PubMed ID: 13641261
    [No Abstract]   [Full Text] [Related]  

  • 13. [Studies on lipocaic; effect of prolonged administration of lipocaic on glucose and lipase levels in the blood in diabetics].
    PEGNI U; BEFANI A
    Riv Crit Clin Med; 1952 Mar; 52(1-2):69-83. PubMed ID: 13056480
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum phospholipid-cholesterol ratios in coronary atherosclerosis. II. Response to lipotropic agents.
    MORRISON LM
    Angiology; 1953 Apr; 4(2):130-3. PubMed ID: 13040818
    [No Abstract]   [Full Text] [Related]  

  • 15. [On the problem of effect of the lipocaic factor on essential hyperlipemia].
    KAEMMERER J; WRADJALIEW J
    Dtsch Gesundheitsw; 1961 Oct; 16():1953-8. PubMed ID: 14453016
    [No Abstract]   [Full Text] [Related]  

  • 16. [On the mechanism of the action of the lipotropic factors. I. Metabolism of the ketone bodies in the liver of depancreatized animals treated or not with lipocaic].
    PITTONI A; ROSSI CR
    Arch Sci Biol (Bologna); 1953; 37(2):169-76. PubMed ID: 13066237
    [No Abstract]   [Full Text] [Related]  

  • 17. On the lipotropic action of lipocaic.
    BRUUN P; DAM H; SCHILLING K
    Acta Physiol Scand; 1950 May; 20(4):319-28. PubMed ID: 15425359
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of various kinds of drugs on serum lipid and atherosclerosis.
    Wu CC; Hsu CJ; Chen JS
    Taiwan Yi Xue Hui Za Zhi; 1967 Feb; 66(2):51-7. PubMed ID: 4172128
    [No Abstract]   [Full Text] [Related]  

  • 19. The metabolism of chylomicra. I. The removal of palmitic acid-1-C14 labeled chylomicra from dog plasma.
    FREDRICKSON DS; HAVEL RJ
    J Clin Invest; 1956 Sep; 35(9):1025-32. PubMed ID: 13367199
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical results of lipocaic-heparin mixture in arteriosclerotic patients and physico-chemical modifications of blood lipoproteins].
    BONO F; CORTINOVIS R
    Minerva Chir; 1955 Jul; 10(14):685-8. PubMed ID: 13279621
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.